There are two major stumbling blocks to developing effective drugs for Alzheimer's, Parkinson's, and other diseases that destroy the brain. The first is overcoming the blood-brain barrier, and the second is delivering the drug to a precise location and ensuring that it does not spread to the rest of the brain. New research finds a